Ironwood Pharmaceuticals, Inc. (IRWD) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Ironwood Pharmaceuticals, Inc.
We certainly think that this might be the case, particularly if you consider IRWD’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as IRWD has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.